Black Titan (NASDAQ:BTTC – Get Free Report) and Zenvia (NASDAQ:ZENV – Get Free Report) are both small-cap technology companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, earnings, institutional ownership, dividends, valuation, analyst recommendations and risk.
Profitability
This table compares Black Titan and Zenvia’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Black Titan | N/A | N/A | N/A |
| Zenvia | -10.62% | -14.36% | -6.52% |
Analyst Recommendations
This is a breakdown of current ratings and recommmendations for Black Titan and Zenvia, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Black Titan | 1 | 0 | 0 | 0 | 1.00 |
| Zenvia | 1 | 0 | 0 | 0 | 1.00 |
Insider and Institutional Ownership
49.2% of Zenvia shares are held by institutional investors. 0.7% of Black Titan shares are held by company insiders. Comparatively, 78.4% of Zenvia shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
Valuation and Earnings
This table compares Black Titan and Zenvia”s gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Black Titan | $2.68 million | 1.61 | -$4.71 million | ($2.95) | -0.10 |
| Zenvia | $1.10 billion | 0.02 | -$28.67 million | ($0.40) | -1.17 |
Black Titan has higher earnings, but lower revenue than Zenvia. Zenvia is trading at a lower price-to-earnings ratio than Black Titan, indicating that it is currently the more affordable of the two stocks.
Volatility and Risk
Black Titan has a beta of 1.21, indicating that its share price is 21% more volatile than the S&P 500. Comparatively, Zenvia has a beta of 1.86, indicating that its share price is 86% more volatile than the S&P 500.
About Black Titan
Titan Pharmaceuticals, Inc. is a biopharmaceutical company developingproprietary therapeutics for the treatment of central nervous system disorders, cancer, and other serious and life threatening diseases. In the central nervous system arena, the company is developing iloperidone, which is clinical testing for schizophrenia through a licensing and development agreement with Novartis Pharma AG. Novartis has tradenamed the product Zomaril.
About Zenvia
Zenvia is a Brazilian technology company that provides cloud-based customer experience and business communication software. Its platform helps organizations manage interactions with customers across digital channels and automate communications and service workflows. The company’s offerings include messaging and communication tools that support channels such as SMS, WhatsApp, email, voice and web chat, along with software for customer service, marketing campaigns and conversational automation. Businesses can use these tools to coordinate customer interactions throughout the customer lifecycle.
Receive News & Ratings for Black Titan Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Black Titan and related companies with MarketBeat.com's FREE daily email newsletter.
